Chapter 90Fundamentals of Cutaneous Photobiology and PhotoimmunologyIrene E. Kochevar, Charles R. Taylor, & Jean Krutmann

REFERENCEs

1. Anders A et al: Action spectrum for erythema in humans investigated with dye lasers. Photochem Photobiol 61:200, 1995

2. de Gruijl FR, Van der Leun JC: Estimate of the wavelength dependency of ultraviolet carcino-genesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion. Health Phys 67:319, 1994

3. Parrish JA, Jaenicke KF: Action spectrum for pho-totherapy of psoriasis. J Invest Dermatol 76:359, 1981

4. Trehan M, Taylor CR: Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 47:701, 2002

5. Sobanko JF, Alster TS: Efficacy of low-level laser therapy for chronic cutaneous ulceration in humans: A review and discussion. Dermatol Surg 34:991, 2008

6. de Gruijl FR et al: Health effects from stratospher-ic ozone depletion and interactions with climate change. Photochem Photobiol Sci 2:16, 2003

7. Slaper H et al: Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384:256, 1996

8. el-Ghorr AA, Norval M: Biological effects of narrow-band (311 nm TL01) UVB irradiation: A review. J Photochem Photobiol B. 38:99, 1997

9. Green C et al: 311 nm UVB phototherapy—An effective treatment for psoriasis. Br J Dermatol 119:691, 1988

10. Anderson RR, Parrish JA: The optics of human skin. J Invest Dermatol 77:13, 1981

11. Baier J et al: Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin. J Invest Dermatol 127:1498, 2007

12. Pinnell SR: Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 48:1, 2003

13. Wan Y et al: UV-induced expression of GADD45 is mediated by an oxidant sensitive pathway in cultured human keratinocytes and in human skin in vivo. Int J Mol Med 6:683, 2000

14. Wang H, Kochevar IE: Involvement of UVB-induced reactive oxygen species in TGF-beta biosynthesis and activation in keratinocytes. Free Radic Biol Med 38:890, 2005

15. Rhodes LE et al: The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 23:3947, 2009

16. Kokot A et al: Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology 150:3197, 2009

17. Enk CD et al: The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 25:2601, 2006

18. Magnus IA et al: Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet 2:448, 1961

19. Parrish JA et al: Erythema and melanogenesis action spectra of normal human skin. Photochem Photobiol 36:187, 1982

20. Diffey BL, Farr PM, Oakley AM: Quantitative stud-ies on UVA-induced erythema in human skin. Br J Dermatol 117:57, 1987

21. Rhodes LE et al: Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. J Invest Dermatol 117:880, 2001

22. Gilchrest BA et al: The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol 5:411, 1981

23. Rosario R et al: Histological changes produced in skin by equally erythemogenic doses of UV-A, UV-B, UV-C and UV-A with psoralens. Br J Derma-tol 101:299, 1979

24. Freeman SE et al: Wavelength dependence of pyrimidine dimer formation in DNA of human skin irradiated in situ with ultraviolet light. Proc Natl Acad Sci USA 86:5605, 1989

534 Chapter 90: Fundamentals of Cutaneous Photobiology and Photoimmunology

Copyright© McGraw-Hill Companies, Inc. All rights reserved.

25. Yarosh D et al: Enzyme therapy of xeroderma pigmentosum: safety and efficacy testing of T4N5 liposome lotion containing a prokaryotic DNA repair enzyme. Photodermatol Photoimmunol Photomed 12:122, 1996

26. Walker SL, Young AR: An action spectrum (290–320 nm) for TNFalpha protein in human skin in vivo suggests that basal-layer epidermal DNA is the chromophore. Proc Natl Acad Sci USA 104:19051, 2007

27. Muthusamy V, Piva TJ: The UV response of the skin: a review of the MAPK, NFkappaB and TNFal-pha signal transduction pathways. Arch Dermatol Res 302:5, 2010

28. Van Laethem A, Garmyn M, Agostinis P: Starting and propagating apoptotic signals in UVB irradi-ated keratinocytes. Photochem Photobiol Sci 8:299, 2009

29. Fritsche E et al: Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 104:8851, 2007

30. McArdle F et al: Effects of oral vitamin E and beta-carotene supplementation on ultraviolet radiation-induced oxidative stress in human skin. Am J Clin Nutr 80:1270, 2004

31. Murray JC et al: A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation. J Am Acad Dermatol 59:418, 2008

32. Farr PM, Diffey BL: A quantitative study of the effect of topical indomethacin on cutaneous erythema induced by UVB and UVC radiation. Br J Dermatol 115:453, 1986

33. Warren JB, Loi RK, Coughlan ML: Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br J Pharmacol 109:802, 1993

34. Farr PM, Diffey BL, Humphreys F: A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation. J Invest Dermatol 87:771, 1986

35. Barr RM et al: Suppressed alloantigen presenta-tion, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 112:692, 1999

36. Murphy GM et al: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatol 6:268, 1989

37. Oxholm A: Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans. APMIS Suppl 24:1, 1992

38. Strickland I et al: TNF-alpha and IL-8 are upregu-lated in the epidermis of normal human skin after UVB exposure: Correlation with neutrophil accumulation and E-selectin expression. J Invest Dermatol 108:763, 1997

39. Gilchrest BA et al: Histologic changes associated with ultraviolet A-induced erythema in normal human skin. J Am Acad Dermatol 9:213, 1983

40. Auletta M et al: Effect of cutaneous hypoxia upon erythema and pigment responses to UVA, UVB, and PUVA (8-MOP + UVA) in human skin. J Invest Dermatol 86:649, 1986

41. Herrling T et al: UV-induced free radicals in the skin detected by ESR spectroscopy and imaging using nitroxides. Free Radic Biol Med 35:59, 2003

42. Paunel AN et al: Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mecha-nisms. Free Radic Biol Med 38:606, 2005

43. Hawk JL et al: Increased concentrations of arachi-donic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. J Invest Dermatol 80:496, 1983

44. Hanson D, DeLeo V: Long-wave ultraviolet light induces phospholipase activation in cultured human epidermal keratinocytes. J Invest Dermatol 95:158, 1990

45. Longuet-Perret I, Schmitt D, Viac J: Tumour ne-crosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 138:221, 1998

46. Skov L et al: Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 138:216, 1998

47. Wolf G: The discovery of vitamin D: The contribu-tion of Adolf Windaus. J Nutr 134:1299, 2004

48. Mellanby E: An experimental investigation on rickets. Lancet 196:407, 1919

49. McCollum E et al: Studies on experimental rickets. XXI. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem 53:293, 1922

50. Rajakumar K: Vitamin D, cod-liver oil, sunlight, and rickets: A historical perspective. Pediatrics 112:e132, 2003

Chapter 90: Fundamentals of Cutaneous Photobiology and Photoimmunology 535

Copyright© McGraw-Hill Companies, Inc. All rights reserved.

51. Hess A, Unger L: The cure of infantile rickets by artificial light and by sunlight. Proc Soc Exp Biol Med 18:298, 1921

52. Chick H et al: The aetiology of rickets in infants: prophylactic and curative observations at the Vienna University Kinderklinik. Lancet ii:7, 1922

53. Huldschinsky K: Heilung von Rachitis durch künstliche Höhensonne. Dtsch Med Wochenschr 45:712, 1919

54. Hess A, Weinstock M, Heelman F: The antirachitic value of irradiated phytosterol and cholesterol. J Biol Chem 63:305, 1925

55. Velluz L, Amiard G, Goffinet B: Le précalciferol. Structure et photochimie. Son role dans le genése di calciferol, et des photoisoméres de l’ergostérol. Bull Soc Chim France 22:1341, 1955

56. Holick MF et al: Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 210:203, 1980

57. Lee P et al: Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 122:1056, 2009

58. Dawson-Hughes B et al: Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 65:67, 1997

59. Looker AC et al: Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771, 2002

60. McKenna MJ: Differences in vitamin D status be-tween countries in young adults and the elderly. Am J Med 93:69, 1992

61. Nesby-O’Dell S et al: Hypovitaminosis D preva-lence and determinants among African American and white women of reproductive age: Third Na-tional Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76:187, 2002

62. Parikh SJ et al: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentra-tions in healthy adults. J Clin Endocrinol Metab 89:1196, 2004

63. Steingrimsdottir L et al: Relationship between serum parathyroid hormone levels, vitamin D suf-ficiency, and calcium intake. JAMA 294:2336, 2005

64. Theiler R et al: Calcidiol, calcitriol and parathyroid hormone serum concentrations in institutional-ized and ambulatory elderly in Switzerland. Int J Vitam Nutr Res 69:96, 1999

65. Webb AR, Kline L, Holick MF: Influence of season and latitude on the cutaneous synthesis of vitamin D3: Exposure to winter sunlight in Boston

and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373, 1988

66. Hathcock JN et al: Risk assessment for vitamin D. Am J Clin Nutr 85:6, 2007

67. Whiting SJ, Calvo MS: Overview of the proceed-ings from Experimental Biology 2005 symposium: Optimizing Vitamin D Intake for Populations with Special Needs: Barriers to Effective Food Fortifica-tion and Supplementation. J Nutr 136:1114, 2006

68. MacLaughlin JA, Anderson RR, Holick MF: Spec-tral character of sunlight modulates photosyn-thesis of previtamin D3 and its photoisomers in human skin. Science 216:001, 1982

69. Norman AW: Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: Integral components of the vitamin D endocrine system. Am J Clin Nutr 67:1108, 1998

70. Holick MF, Matsuoka LY, Wortsman J: Age, vitamin D, and solar ultraviolet. Lancet 2:1104, 1989

71. Wortsman J et al: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690, 2000

72. Holick MF: Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 61:638S, 1995

73. Vieth R: Vitamin D supplementation, 25-hy-droxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842, 1999

74. Matsuoka LY et al: Sunscreens suppress cutane-ous vitamin D3 synthesis. J Clin Endocrinol Metab 64:1165, 1987

75. Binkley N et al: Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 92:2130, 2007

76. Gonzalez G et al: High prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: Additional evidence for a worldwide concern. Menopause 14:455, 2007

77. Jacobs ET et al: Vitamin D insufficiency in south-ern Arizona. Am J Clin Nutr 87:608, 2008

78. Kimlin M et al: Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B 89:139, 2007

79. Levis S et al: Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab 90:1557, 2005

80. Rhodes LE et al: Recommended summer sunlight exposure levels can produce sufficient (>20 ng ml-1) but not the proposed optimal (>32 ng ml-1) 25 (OH)D levels at UK latitudes. J Invest Dermatol 130:1411, 2010

536 Chapter 90: Fundamentals of Cutaneous Photobiology and Photoimmunology

Copyright© McGraw-Hill Companies, Inc. All rights reserved.

81. Bischoff-Ferrari HA et al: Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24:935, 2009

82. Bischoff-Ferrari HA et al: Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 293:2257, 2005

83. Cranney A et al: Summary of evidence-based re-view on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 88:513S, 2008

84. Dawson-Hughes B: Serum 25-hydroxyvitamin D and functional outcomes in the elderly. Am J Clin Nutr 88:537S, 2008

85. O’Donnell S et al: Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 26:531, 2008

86. Wolpowitz D, Gilchrest BA: The vitamin D ques-tions: How much do you need and how should you get it? J Am Acad Dermatol 54:301, 2006

87. Chlebowski RT et al: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100:1581, 2008

88. Feskanich D et al: Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502, 2004

89. Garland CF et al: Vitamin D and prevention of breast cancer: Pooled analysis. J Steroid Biochem Mol Biol 103:708, 2007

90. Gorham ED et al: Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 32:210, 2007

91. Wactawski-Wende J et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 354:684, 2006

92. Waltz P, Chodick G: Assessment of ecological regression in the study of colon, breast, ovary, non-Hodgkin’s lymphoma, or prostate cancer and residential UV. Eur J Cancer Prev 17:279, 2008

93. Chiu KC et al: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79:820, 2004

94. Scragg R et al: Serum 25-hydroxyvitamin D, dia-betes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813, 2004

95. Munger KL et al: Serum 25-hydroxyvitamin D lev-els and risk of multiple sclerosis. JAMA 296:2832, 2006

96. Forman JP et al: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hyper-tension 49:1063, 2007

97. Giovannucci E et al: 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 168:1174, 2008

98. Dobnig H et al: Independent association of low serum 25-hydroxyvitamin d and 1,25-dihy-droxyvitamin d levels with all-cause and car-diovascular mortality. Arch Intern Med 168:1340, 2008

99. Gloth FM, 3rd, Alam W, Hollis B: Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 3:5, 1999

100. Straube S et al: Vitamin D and chronic pain. Pain 141:10, 2009

101. Melamed ML et al: 25-hydroxyvitamin D levels and the risk of mortality in the general popula-tion. Arch Intern Med 168:1629, 2008

102. Llewellyn DJ et al: Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22:188, 2009

103. Cannell JJ et al: Epidemic influenza and vitamin D. Epidemiol Infect 134:1129, 2006

104. Liu PT et al: Toll-like receptor triggering of a vita-min D-mediated human antimicrobial response. Science 311:1770, 2006

105. Evatt ML et al: Prevalence of vitamin D insuf-ficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65:1348, 2008

106. Wang TJ et al: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503, 2008

107. Bischoff-Ferrari HA et al: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18, 2006

108. Vieth R et al: The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 85:649, 2007

109. Donawho C et al: Photoimmumology of cuta-nous melanoma, In: Photoimmumology, edited by J Krutmann and C Elmets. Oxford, Cambridge, Boston, MA, Blackwell Science, 1995, p. 119

110. Grabbe S et al: Photoimmunology of UV-induced skin cancer. In: Photoimmunology, edited by J Krutmann and C Elmets. Oxford, Cambridge, Boston, MA, Blackwell Science, 1995, p. 99

111. Kripke ML: Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 53:1333, 1974

Chapter 90: Fundamentals of Cutaneous Photobiology and Photoimmunology 537

Copyright© McGraw-Hill Companies, Inc. All rights reserved.

112. Kripke ML: Effects of UV radiation on tumor im-munity. J Natl Cancer Inst 82:1392, 1990

113. Kripke ML et al: In vivo immune responses of mice during carcinogenesis by ultraviolet irradia-tion. J Natl Cancer Inst 59:1227, 1977

114. Schade N, Esser C, Krutmann J: Ultraviolet B ra-diation-induced immunosuppression: molecular mechanisms and cellular alterations. Photochem Photobiol Sci 4:699, 2005

115. Kripke ML, Morison WL: Modulation of immune function by UV radiation. J Invest Dermatol 85:62s, 1985

116. Yoshikawa T, Streilein JW: Genetic basis of the ef-fects of ultraviolet light B on cutaneous immunity. Evidence that polymorphism at the Tnfa and Lps loci governs susceptibility. Immunogenetics 32:398, 1990

117. Applegate LA et al: Identification of the molecular target for the suppression of contact hypersensi-tivity by ultraviolet radiation. J Exp Med 170:1117, 1989

118. Kripke ML et al: Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 89:7516, 1992

119. Vink AA et al: Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med 183:1491, 1996

120. Stege H et al: Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 97:1790, 2000

121. Katiyar SK et al: Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Pho-tochem Photobiol 62:855, 1995

122. Rosette C, Karin M: Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194, 1996

123. Walterscheid JP, Ullrich SE, Nghiem DX: Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 195:171, 2002

124. Rockel N et al: The osmolyte taurine protects against ultraviolet B radiation-induced immuno-suppression. J Immunol 179:3604, 2007

125. De Fabo EC, Noonan FP: Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photore-ceptor in skin and its role in photoimmunology. J Exp Med 158:84, 1983

126. Luger T, Schwarz T: Effects of UV light on cyto-kines and neuroendocrine hormones, In: Photo-immunology, edited by Krutmann and C Elmets. Boston, MA, Blackwell Science; 1995, p. 55

127. Kang K et al: CD11b +macrophages that infiltrate human epidermis after in vivo ultraviolet expo-sure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 153:5256, 1994

128. Ullrich SE, Schmitt DA: The role of cytokines in UV-induced systemic immune suppression. J Dermatol Sci 23(Suppl 1):S10, 2000

129. Rivas JM, Ullrich SE: Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 149:3865, 1992

130. Toews GB, Bergstresser PR, Streilein JW: Epider-mal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness fol-lows skin painting with DNFB. J Immunol 124:445, 1980

131. Schwarz A et al: Interleukin-12 suppresses ultra-violet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 4:26, 2002

132. Krutmann J et al: Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells. J Clin Invest 85:1529, 1990

133. Tang A, Udey MC: Inhibition of epidermal Langer-hans cell function by low dose ultraviolet B radia-tion. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells. J Immunol 146:3347, 1991

134. Moodycliffe AM, Kimber I, Norval M: The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology 77:394, 1992

135. Kolgen W et al: Epidermal langerhans cell deple-tion after artificial ultraviolet B irradiation of human skin in vivo: Apoptosis versus migration. J Invest Dermatol 118:812, 2002

136. Simon JC et al: Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4 +cells of the T helper 2 subset. J Immunol 145:2087, 1990

137. Simon JC et al: Ultraviolet B radiation converts Langerhans cells from immunogenic to tolero-genic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 146:485, 1991

538 Chapter 90: Fundamentals of Cutaneous Photobiology and Photoimmunology

Copyright© McGraw-Hill Companies, Inc. All rights reserved.

138. Hammerberg C, Duraiswamy N, Cooper KD: Re-versal of immunosuppression inducible through ultraviolet-exposed skin by in vivo anti-CD11b treatment. J Immunol 157:5254, 1996

139. Schwarz T: Ultraviolet radiation-induced toler-ance. Allergy 54:1252, 1999

140. Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW: Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 158:781, 1983

141. Schwarz A et al: Interleukin 12 breaks ultraviolet light induced immunosuppression by affecting CD8+ rather than CD4+ T cells. J Invest Dermatol 110:272, 1998

142. Schwarz A et al: Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced toler-ance. J Immunol 165:1824, 2000

143. Shreedhar VK et al: Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 161:1327, 1998

144. Glaser R et al: UV-B radiation induces the expres-sion of antimicrobial peptides in human kerati-nocytes in vitro and in vivo. J Allergy Clin Immunol 123:1117, 2009

145. Krutmann J, Yarosh D: Modern photoprotection of human skin. In: Skin Aging, edited by BA Gil-chrest and J Krutmann. New York, Springer Berlin Heidelberg, 2006, p. 103